These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36680220)

  • 1. Decreased Clinical Severity of Pediatric Acute COVID-19 and MIS-C and Increase of Incidental Cases during the Omicron Wave in Comparison to the Delta Wave.
    Kenney PO; Chang AJ; Krabill L; Hicar MD
    Viruses; 2023 Jan; 15(1):. PubMed ID: 36680220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Admission to the Pediatric Intensive Care Unit for SARS-CoV-2 Delta and Omicron Infections.
    Recher M; Leteurtre S; Javouhey E; Morin L; Baudin F; Rambaud J; Mortamet G; Hubert H; Angoulvant F; Levy M;
    J Pediatric Infect Dis Soc; 2023 Apr; 12(4):189-197. PubMed ID: 36786499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MIS-C across three SARS-CoV-2 variants: Changes in COVID-19 testing and clinical characteristics in a cohort of U.S. children.
    Laird-Gion J; Dionne A; Gauvreau K; Baker A; Day-Lewis M; de Ferranti S; Friedman K; Khan N; Mahanta S; Son MB; Sperotto F; Newburger JW
    Eur J Pediatr; 2023 Jun; 182(6):2865-2872. PubMed ID: 37055630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal and perinatal outcomes of SARS-CoV-2 infection in unvaccinated pregnancies during Delta and Omicron waves.
    Birol Ilter P; Prasad S; Mutlu MA; Tekin AB; O'Brien P; von Dadelszen P; Magee LA; Tekin S; Tug N; Kalafat E; Khalil A
    Ultrasound Obstet Gynecol; 2022 Jul; 60(1):96-102. PubMed ID: 35441407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 Hospitalization Among Children <18 Years by Variant Wave in Norway.
    Whittaker R; Greve-Isdahl M; Bøås H; Suren P; Buanes EA; Veneti L
    Pediatrics; 2022 Sep; 150(3):. PubMed ID: 35916036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and Postacute COVID-19 Outcomes Among Immunologically Naive Adults During Delta vs Omicron Waves.
    Doll MK; Waghmare A; Heit A; Levenson Shakoor B; Kimball LE; Ozbek N; Blazevic RL; Mose L; Boonyaratanakornkit J; Stevens-Ayers TL; Cornell K; Sheppard BD; Hampson E; Sharmin F; Goodwin B; Dan JM; Archie T; O'Connor T; Heckerman D; Schmitz F; Boeckh M; Crotty S
    JAMA Netw Open; 2023 Feb; 6(2):e231181. PubMed ID: 36853602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paediatric admissions with SARS-CoV-2 during the Delta and Omicron waves: an Australian single-centre retrospective study.
    Cheng DR; Schrader S; McMinn A; Crawford NW; Tosif S; Mcnab S; Steer AC
    BMJ Paediatr Open; 2023 Mar; 7(1):. PubMed ID: 36882231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical severity of COVID-19 in patients admitted to hospital during the omicron wave in South Africa: a retrospective observational study.
    Jassat W; Abdool Karim SS; Mudara C; Welch R; Ozougwu L; Groome MJ; Govender N; von Gottberg A; Wolter N; Wolmarans M; Rousseau P; ; Blumberg L; Cohen C
    Lancet Glob Health; 2022 Jul; 10(7):e961-e969. PubMed ID: 35597249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.
    Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics, outcome, duration of hospitalization, and cycle threshold of patients with COVID-19 referred to four hospitals in Babol City: a multicenter retrospective observational study on the fourth, fifth, and sixth waves.
    Sadeghi F; Halaji M; Shirafkan H; Pournajaf A; Ghorbani H; Babazadeh S; Ezami N; Fallhpour K; Fakhraie F; Gorjinejad S; Amoli SS; Amiri FH; Baghershiroodi M; Ahmadnia Z; Salehi M; Tourani M; Jafarzadeh J; Tabari FS; Ahmadian SR; Mohammadi Abandansari R; Jafarian F; Rouhi S; Zabihollahi A; Mostafanezhad S; Saeedi F; Ebrahimian A; Deldar Z; Zavareh MSH; Bayani M; Broun MB; Shirzad M; Sabbaghi S; Mohammadi M; Rahmani R; Yahyapour Y
    BMC Infect Dis; 2024 Jan; 24(1):55. PubMed ID: 38184533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Admissions to a large tertiary care hospital and Omicron BA.1 and BA.2 SARS-CoV-2 polymerase chain reaction positivity: primary, contributing, or incidental COVID-19.
    Voor In 't Holt AF; Haanappel CP; Rahamat-Langendoen J; Molenkamp R; van Nood E; van den Toorn LM; Peeters RP; van Rossum AMC; Severin JA
    Int J Infect Dis; 2022 Sep; 122():665-668. PubMed ID: 35842214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change in Severity and Clinical Manifestation of MIS-C Over SARS-CoV-2 Variant Outbreaks in Korea.
    Choe YJ; Choi EH; Choi JW; Eun BW; Eun LY; Kim YJ; Kim YH; Kim YA; Kim YK; Kwak JH; Lee H; Park JD; Jung YH; Gwack J; Lee S;
    J Korean Med Sci; 2023 Jul; 38(30):e225. PubMed ID: 37527908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective Observational Study of Complete Blood Count (CBC) Parameters and ICU Mortality of COVID-19 Disease in Delta Variant and Omicron Variant in a Community-Based Hospital in New York City.
    Yadav R; Yadav V; Pokhriyal S; Zahid U; Gandhi A
    Cureus; 2023 Feb; 15(2):e34894. PubMed ID: 36925973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa.
    Abdullah F; Myers J; Basu D; Tintinger G; Ueckermann V; Mathebula M; Ramlall R; Spoor S; de Villiers T; Van der Walt Z; Cloete J; Soma-Pillay P; Rheeder P; Paruk F; Engelbrecht A; Lalloo V; Myburg M; Kistan J; van Hougenhouck-Tulleken W; Boswell MT; Gray G; Welch R; Blumberg L; Jassat W
    Int J Infect Dis; 2022 Mar; 116():38-42. PubMed ID: 34971823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.
    Ali AM; Tofiq AM; Rostam HM; Ali KM; Tawfeeq HM
    J Med Virol; 2022 Dec; 94(12):5867-5876. PubMed ID: 36029103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 B.1.1.529 (Omicron) Variant Causes an Unprecedented Surge in Children Hospitalizations and Distinct Clinical Presentation Compared to the SARS-CoV-2 B.1.617.2 (Delta) Variant.
    Taytard J; Prevost B; Schnuriger A; Aubertin G; Berdah L; Bitton L; Dupond-Athenor A; Thouvenin G; Nathan N; Corvol H
    Front Pediatr; 2022; 10():932170. PubMed ID: 35832582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
    Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous manifestations of SARS-CoV-2 infection during the Delta and Omicron waves in 348 691 UK users of the UK ZOE COVID Study app.
    Visconti A; Murray B; Rossi N; Wolf J; Ourselin S; Spector TD; Freeman EE; Bataille V; Falchi M
    Br J Dermatol; 2022 Dec; 187(6):900-908. PubMed ID: 35869671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease in COVID-19 adverse outcomes in adults during the Delta and Omicron SARS-CoV-2 waves, after vaccination in Mexico.
    Domínguez-Ramírez L; Solis-Tejeda I; Ayon-Aguilar J; Mayoral-Ortiz A; Sosa-Jurado F; Pelayo R; Santos-López G; Cortes-Hernandez P
    Front Public Health; 2022; 10():1010256. PubMed ID: 36176536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
    Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN
    Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.